(Q36280431)

13 August 2017

1 reference

title

Humoral rejection of organ allografts (English)

1 reference

13 August 2017

Solange Moll

1

1 reference

13 August 2017

Manuel Pascual

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

American Journal of Transplantation

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

2611-2618

1 reference

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

The role of B cells and alloantibody in the host response to human organ allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Banff 2003 meeting report: new diagnostic insights and standards.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Novel rescue therapy for C4d-positive acute humoral renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Tortuosity of the white matter medullary arterioles is related to the severity of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Managing the highly sensitized transplant recipient and B cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Strategies to improve long-term outcomes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Two levels of help for B cell alloantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Immunosuppressive drugs for kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Antibody, complement and accommodation in ABO-incompatible transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Incidence of acute cellular rejection and non-cellular rejection in cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01086.X

10.1111/J.1600-6143.2005.01086.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference